Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Neural Damage in Experimental Trypanosoma brucei gambiense Infection: Hypothalamic Peptidergic Sleep and Wake-Regulatory Neurons.

Laperchia C, Xu YZ, Mumba Ngoyi D, Cotrufo T, Bentivoglio M.

Front Neuroanat. 2018 Feb 27;12:13. doi: 10.3389/fnana.2018.00013. eCollection 2018.

2.

Prostaglandin D2 Receptor DP1 Antibodies Predict Vaccine-induced and Spontaneous Narcolepsy Type 1: Large-scale Study of Antibody Profiling.

Sadam H, Pihlak A, Kivil A, Pihelgas S, Jaago M, Adler P, Vilo J, Vapalahti O, Neuman T, Lindholm D, Partinen M, Vaheri A, Palm K.

EBioMedicine. 2018 Mar;29:47-59. doi: 10.1016/j.ebiom.2018.01.043. Epub 2018 Feb 2.

3.

Clinical update on central hypersomnias.

Pérez-Carbonell L, Leschziner G.

J Thorac Dis. 2018 Jan;10(Suppl 1):S112-S123. doi: 10.21037/jtd.2017.10.161. Review.

4.

Nocturnal REM Sleep Without Atonia Is a Diagnostic Biomarker of Pediatric Narcolepsy.

Bin-Hasan S, Videnovic A, Maski K.

J Clin Sleep Med. 2018 Feb 15;14(2):245-252. doi: 10.5664/jcsm.6944.

PMID:
29351827
5.

Increased acetylcholine and glutamate efflux in the prefrontal cortex following intranasal orexin-A (hypocretin-1).

Calva CB, Fayyaz H, Fadel JR.

J Neurochem. 2018 May;145(3):232-244. doi: 10.1111/jnc.14279. Epub 2018 Jan 12.

PMID:
29250792
6.

Autoimmunity in narcolepsy.

Bonvalet M, Ollila HM, Ambati A, Mignot E.

Curr Opin Pulm Med. 2017 Nov;23(6):522-529. doi: 10.1097/MCP.0000000000000426. Review.

PMID:
28991006
7.

The Medical and Economic Burden of Narcolepsy: Implications for Managed Care.

Thorpy MJ, Hiller G.

Am Health Drug Benefits. 2017 Jul;10(5):233-241. Review.

8.

Diurnal fluctuation in the number of hypocretin/orexin and histamine producing: Implication for understanding and treating neuronal loss.

McGregor R, Shan L, Wu MF, Siegel JM.

PLoS One. 2017 Jun 1;12(6):e0178573. doi: 10.1371/journal.pone.0178573. eCollection 2017.

9.

Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and Histamine in Narcolepsy.

Lopez R, Barateau L, Evangelista E, Chenini S, Robert P, Jaussent I, Dauvilliers Y.

Sleep. 2017 Jan 1;40(1). doi: 10.1093/sleep/zsw010.

10.

CD4+ T-Cell Reactivity to Orexin/Hypocretin in Patients With Narcolepsy Type 1.

Ramberger M, Högl B, Stefani A, Mitterling T, Reindl M, Lutterotti A.

Sleep. 2017 Mar 1;40(3). doi: 10.1093/sleep/zsw070.

11.

Normal Morning Melanin-Concentrating Hormone Levels and No Association with Rapid Eye Movement or Non-Rapid Eye Movement Sleep Parameters in Narcolepsy Type 1 and Type 2.

Schrölkamp M, Jennum PJ, Gammeltoft S, Holm A, Kornum BR, Knudsen S.

J Clin Sleep Med. 2017 Feb 15;13(2):235-243. doi: 10.5664/jcsm.6454.

12.

From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluid.

Hirtz C, Vialaret J, Gabelle A, Nowak N, Dauvilliers Y, Lehmann S.

Sci Rep. 2016 May 11;6:25162. doi: 10.1038/srep25162.

13.

Challenges in the development of therapeutics for narcolepsy.

Black SW, Yamanaka A, Kilduff TS.

Prog Neurobiol. 2017 May;152:89-113. doi: 10.1016/j.pneurobio.2015.12.002. Epub 2015 Dec 23. Review.

14.

Is suvorexant a better choice than alternative hypnotics?

Kripke DF.

F1000Res. 2015 Aug 3;4:456. doi: 10.12688/f1000research.6845.1. eCollection 2015.

15.

Narcolepsy and the Sickness Impact Profile: A general health status measure.

Ton TG, Watson NF, Koepsell TD, Longstreth WT.

Sleep Sci. 2014 Mar;7(1):5-12. doi: 10.1016/j.slsci.2014.07.001. Epub 2014 Aug 19.

16.

Primary progressive narcolepsy type 1: the other side of the coin.

Pizza F, Vandi S, Liguori R, Parchi P, Avoni P, Mignot E, Plazzi G.

Neurology. 2014 Dec 2;83(23):2189-90. doi: 10.1212/WNL.0000000000001051. Epub 2014 Oct 29. No abstract available.

17.

Dysautonomia in narcolepsy: evidence by questionnaire assessment.

Klein G, Burghaus L, Vaillant M, Pieri V, Fink GR, Diederich N.

J Clin Neurol. 2014 Oct;10(4):314-9. doi: 10.3988/jcn.2014.10.4.314. Epub 2014 Oct 6.

18.

Challenges in diagnosing narcolepsy without cataplexy: a consensus statement.

Baumann CR, Mignot E, Lammers GJ, Overeem S, Arnulf I, Rye D, Dauvilliers Y, Honda M, Owens JA, Plazzi G, Scammell TE.

Sleep. 2014 Jun 1;37(6):1035-42. doi: 10.5665/sleep.3756.

19.

Etiopathogenesis and neurobiology of narcolepsy: a review.

Kumar S, Sagili H.

J Clin Diagn Res. 2014 Feb;8(2):190-5. doi: 10.7860/JCDR/2014/7295.4057. Epub 2013 Dec 27. Review.

20.

A physiologically based model of orexinergic stabilization of sleep and wake.

Fulcher BD, Phillips AJ, Postnova S, Robinson PA.

PLoS One. 2014 Mar 20;9(3):e91982. doi: 10.1371/journal.pone.0091982. eCollection 2014.

Supplemental Content

Support Center